This is a promotional website fully funded and created by SERB Pharmaceuticals for UK Healthcare Professionals only.
You are viewing the Voraxaze▼ (glucarpidase) website for the United Kingdom.
Certain BTG products may not be available within the chosen
location, and indications may differ from your country’s approved use.
The pooled clinical safety database for Voraxaze® includes data for 232 patients up to 17 years of age.
within the central MTX HPLC population
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
Abbreviations: CIR, clinically important reduction;HPLC, high-performance liquid chromatography; MTX, methotrexate.